Lecture6-For Web.Key

Total Page:16

File Type:pdf, Size:1020Kb

Lecture6-For Web.Key 1 2 Holly Wichman Jim Bull 3 4 Phage Population Growth at 43° C A A* H B K ! X174 C G D E J F 5 6 7 8 9 10 Adaptation for cryptic coloration 11 12 Mouse coat color genetics Endothelin receptor B (piebald) mutation Genes Phenotypes Mouse Adamts20, Ectodysplasin-A (Eda), Endothelin 3 Human ligand (Edn3),Endothelin receptor B (Ednrb) Epidermal growth factor receptor (Egfr), Fibroblast growth factor receptor2 (Fgfr2), Inhibitor of kappaB kinase gamma (Ikbkg), C-kit receptor (kit), Ligand for c-kit receptor (kitl), Keratin complex 2, gene 17 (Krt2-17), LIM homeodomain protein 1 (Lmx1a), Mucolipin 3(Mcoln3), Pax-3 transcription factor (Pax3), Sideroflexin (Sfxn1), Neural crest transcription factor (Snai2), Sry-box containing gene 10 (Sox10), Sry-box containing gene 18 (Sox18), T- box 15 (tbx15), Growth factor (Wnt1), Growth factor (Wnt3a), Tyrosinase-related protein 2 (Tyrp2/Dct), Glycoprotein (Gpnmb), Membrane- assoc. transporter protein (Matp), Member of RAS oncogene family (Rab38), Silver protein (Pmel17), Tyrosinase (Tyr), Tyrosinas-related protein 1 (Tyrp1), Beta 3 subunit of adaptor protein 3 (Ap3b1), Delta subunit of adaptor protein 2 (Ap3d), Vacuoloar protein sorting 33a (Vps33a), Cno, Hermansky-Pudlak syndrome gene 1 (Hps1), Hermansky-Pudlak gene 3 (Hps3), Hermansky-Pudlak gene 4 (Hps4), Hermansky- Pudlak gene 5 (Hps5), Hermansky-Pudlak gene 6 (Hps6), Lysosomal trafficking regulator (Lyst), Ocular albinism type 1 (Oa1), Pallidin (Pldn), Rab geranylgeranyl transferase (Rabgtta), Melanophilin (Mlph), Myosin type Va (Myo5a), Myosin type 7a (Myo7a), RAS associated protein (Rab27a), Agouti signaling protein (Asip), Attractin (atrn), Gamma gluyltranspeptidase 1 (Ggt1), Melanocortin-1 receptor (Mc1r), E3 ubiquitin ligase (Mgrn1), Proopiomelanocortin (Pomc1), ATPase (Atp7a), ATPase (Atp7b), Excision repair deficiancy (Ercc) neutral mutation 13 14 Tyrosinase (albino) mutation Adaptive color polymorphism in rock pocket mice Mouse Human e s u o m habitat O’Neill Hills Pinacate Lava deleterious mutation 2 miles 15 16 Distribution of lava in the SouthWest Phenotypic variation in coat color Pinacates Kenzin Armendaris Carrizozo Pinacates Kenzin Armendaris Carrizozo Age (yrs) 1,700,000 530,000 760,000 1,000 Area (km2) 3500 142 435 329 17 18 Approach: Association studies Eumelanosome phenotype Agouti cAMP t = 1 pulse of agouti expression MSH Mc1r Phaeomelanosome t = 2 Light Dark t = 3 Coding Region 19 20 Mc1Mc1rr polymorphis miss in l igresponsibleht and dark C. intermedius from tforhe Pinac atmelanices color 0 1 2 2 2 3 3 3 4 4 4 6 6 6 7 7 8 9 9 5 2 0 4 9 1 2 2 7 8 9 3 5 9 2 8 1 1 2 Phenotype ID 2 6 5 3 8 3 4 5 8 1 5 3 1 9 0 7 9 5 7 C T C T G G C C C G C T T A T C C C C R R R R R R R R Dark 1371 T . T T . C . C . T . T T . C . C . Dark 1373 T . T T . C . C . T . T T . C . C . s l Dark 1374 T . T T . C . C . T . T T . C . C . a Dark 1375 T . T T . C . C . u T . T T . C . C . Dark 1376 T . T T . C . C . Perfect association between genotype and phenotype d T . T T . C . C . i Dark 1377 T . T T . C . C . v T . T T . C . C . i Mc1r DD Dark 1378 T . T T . C . C . d T . T T . C . C . Dark 1381 T . T T . C . C . n i T . T . T T . C C . Genotype: Mc1r locus Phenotype: coat color Dark 1383 T . T T . C . C . T . T T . C . C . Dark 1385 T . T T . C . C . T . T . T T . C . C . Dark 1386 T . T T . C . C . T . T T . C . C . * Complete Dark 1372 T . T T . C . C . Dark Dark 1379 T . T . T T . C . C . association . melanic Dark 1382 T . T T . C . C . holds for 102 Dark 1384 T . T . T T . C . C . Mc1r Dd . Dark 1412 T . T T . C . C . melanic and 73 . T . Dark 1416 T . T . T T . C . C . T . T . light individuals 1387 . G . T . Dark . G . T . 1402 . T . T . A . T . G . T . 1403 . 1404 . C A . G . T T . 1405 . G . T . A . T . G . T . 1406 . C . Light . C A . G . T T . Mc1r dd 1407 . G . T . 1408 . T . A . C . 1409 . A . T . G . T . 1410 . A . T . G . T . T 1411 . G . T . N = 202 individuals (404 alleles) . A . T . G . T . 1414 . G . T . 21 22 Amino acid mutations in the Mc1r receptor in rock pocket mice extracellular transmembrane intracellular 23 24 Distribution of Mc1r alleles in the Pinacates Arizona Arizona, USA Xmas 5km Tule lava West Mid East O'Neill Sonora, Mexico Substrate color: Coat color: Xmas Tule West Mid East O'Neill F.E.T. Amok Time Sample size: 6 85 7 5 45 77 = 225 P < 10-6 Dice 1947: Studied owl predation in deermice 25 26 Different allele frequency clines in Mc1r and mtDNA selected neutral e e p 1 c y f i e 1 f t c o o m i o y y n m k c r c e d n a n h 0.5 e d D e p 0.5 u u g r q c 1 q n e i c o e r n f r m a M l f a 0 e 0 m s e p 1 f f e 1 y l o o t e l o y y l l c c a p n n a e 0.5 D e 0.5 h u u r q q A 1 e e c N r r f f D M 0 0 t m l l l l i i t t e t s e t s d s e N d s i ’ e N i a ’ a Tule O W M Xmas E M Tule Xmas O E W Sampling locales Sampling locales 27.
Recommended publications
  • Lineage-Specific Evolution of the Vertebrate Otopetrin Gene Family Revealed by Comparative Genomic Analyses
    Hurle et al. BMC Evolutionary Biology 2011, 11:23 http://www.biomedcentral.com/1471-2148/11/23 RESEARCHARTICLE Open Access Lineage-specific evolution of the vertebrate Otopetrin gene family revealed by comparative genomic analyses Belen Hurle1, Tomas Marques-Bonet2,3, Francesca Antonacci3, Inna Hughes4, Joseph F Ryan1, NISC Comparative Sequencing Program1,5, Evan E Eichler3, David M Ornitz6, Eric D Green1,5* Abstract Background: Mutations in the Otopetrin 1 gene (Otop1) in mice and fish produce an unusual bilateral vestibular pathology that involves the absence of otoconia without hearing impairment. The encoded protein, Otop1, is the only functionally characterized member of the Otopetrin Domain Protein (ODP) family; the extended sequence and structural preservation of ODP proteins in metazoans suggest a conserved functional role. Here, we use the tools of sequence- and cytogenetic-based comparative genomics to study the Otop1 and the Otop2-Otop3 genes and to establish their genomic context in 25 vertebrates. We extend our evolutionary study to include the gene mutated in Usher syndrome (USH) subtype 1G (Ush1g), both because of the head-to-tail clustering of Ush1g with Otop2 and because Otop1 and Ush1g mutations result in inner ear phenotypes. Results: We established that OTOP1 is the boundary gene of an inversion polymorphism on human chromosome 4p16 that originated in the common human-chimpanzee lineage more than 6 million years ago. Other lineage- specific evolutionary events included a three-fold expansion of the Otop genes in Xenopus tropicalis and of Ush1g in teleostei fish. The tight physical linkage between Otop2 and Ush1g is conserved in all vertebrates.
    [Show full text]
  • Diagnosing Platelet Secretion Disorders: Examples Cases
    Diagnosing platelet secretion disorders: examples cases Martina Daly Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield Disclosures for Martina Daly In compliance with COI policy, ISTH requires the following disclosures to the session audience: Research Support/P.I. No relevant conflicts of interest to declare Employee No relevant conflicts of interest to declare Consultant No relevant conflicts of interest to declare Major Stockholder No relevant conflicts of interest to declare Speakers Bureau No relevant conflicts of interest to declare Honoraria No relevant conflicts of interest to declare Scientific Advisory No relevant conflicts of interest to declare Board Platelet granule release Agonists (FIIa, Collagen, ADP) Signals Activation Shape change Membrane fusion Release of granule contents Platelet storage organelles lysosomes a granules Enzymes including cathepsins Adhesive proteins acid hydrolases Clotting factors and their inhibitors Fibrinolytic factors and their inhibitors Proteases and antiproteases Growth and mitogenic factors Chemokines, cytokines Anti-microbial proteins Membrane glycoproteins dense (d) granules ADP/ATP Serotonin histamine inorganic polyphosphate Platelet a-granule contents Type Prominent components Membrane glycoproteins GPIb, aIIbb3, GPVI Clotting factors VWF, FV, FXI, FII, Fibrinogen, HMWK, FXIII? Clotting inhibitors TFPI, protein S, protease nexin-2 Fibrinolysis components PAI-1, TAFI, a2-antiplasmin, plasminogen, uPA Other protease inhibitors a1-antitrypsin, a2-macroglobulin
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • 4-6 Weeks Old Female C57BL/6 Mice Obtained from Jackson Labs Were Used for Cell Isolation
    Methods Mice: 4-6 weeks old female C57BL/6 mice obtained from Jackson labs were used for cell isolation. Female Foxp3-IRES-GFP reporter mice (1), backcrossed to B6/C57 background for 10 generations, were used for the isolation of naïve CD4 and naïve CD8 cells for the RNAseq experiments. The mice were housed in pathogen-free animal facility in the La Jolla Institute for Allergy and Immunology and were used according to protocols approved by the Institutional Animal Care and use Committee. Preparation of cells: Subsets of thymocytes were isolated by cell sorting as previously described (2), after cell surface staining using CD4 (GK1.5), CD8 (53-6.7), CD3ε (145- 2C11), CD24 (M1/69) (all from Biolegend). DP cells: CD4+CD8 int/hi; CD4 SP cells: CD4CD3 hi, CD24 int/lo; CD8 SP cells: CD8 int/hi CD4 CD3 hi, CD24 int/lo (Fig S2). Peripheral subsets were isolated after pooling spleen and lymph nodes. T cells were enriched by negative isolation using Dynabeads (Dynabeads untouched mouse T cells, 11413D, Invitrogen). After surface staining for CD4 (GK1.5), CD8 (53-6.7), CD62L (MEL-14), CD25 (PC61) and CD44 (IM7), naïve CD4+CD62L hiCD25-CD44lo and naïve CD8+CD62L hiCD25-CD44lo were obtained by sorting (BD FACS Aria). Additionally, for the RNAseq experiments, CD4 and CD8 naïve cells were isolated by sorting T cells from the Foxp3- IRES-GFP mice: CD4+CD62LhiCD25–CD44lo GFP(FOXP3)– and CD8+CD62LhiCD25– CD44lo GFP(FOXP3)– (antibodies were from Biolegend). In some cases, naïve CD4 cells were cultured in vitro under Th1 or Th2 polarizing conditions (3, 4).
    [Show full text]
  • Discovery of Genes Required for Body Axis and Limb Formation by Global Identification of Conserved Retinoic Acid Regulated Enhancers and Silencers
    bioRxiv preprint doi: https://doi.org/10.1101/778191; this version posted December 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Discovery of genes required for body axis and limb formation by global identification of conserved retinoic acid regulated enhancers and silencers Marie Berenguer1, Karolin F. Meyer1, Jun Yin2, and Gregg Duester1,* 1Development, Aging, and Regeneration Program 2Bioinformatics Core Facility Sanford Burnham Prebys Medical Discovery Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA *Corresponding Author ([email protected]) Keywords: Body axis formation; retinoic acid signaling; enhancer; silencer; Aldh1a2 knockout; Nr2f1; Nr2f2 Short title: RNA-seq/ChIP-seq to find RA target genes 1 bioRxiv preprint doi: https://doi.org/10.1101/778191; this version posted December 17, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Identification of target genes for transcription factors is hampered by the large number of genes whose expression changes when the factor is removed from a specific tissue and the numerous binding sites for the factor in the genome. Retinoic acid (RA) regulates transcription via RA receptors bound to RA response elements (RAREs) of which there are thousands in vertebrate genomes. Here, we combined ChIP-seq and RNA-seq on trunk tissue from wild-type and Aldh1a2-/- embryos lacking RA synthesis that exhibit body axis and forelimb defects. We identified a relatively small number of genes with altered expression when RA is missing that also have nearby RA- regulated deposition of H3K27ac (gene activation mark) or H3K27me3 (gene repression mark) associated with conserved RAREs.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Supplementary Material
    BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Page 1 / 45 SUPPLEMENTARY MATERIAL Appendix A1: Neuropsychological protocol. Appendix A2: Description of the four cases at the transitional stage. Table A1: Clinical status and center proportion in each batch. Table A2: Complete output from EdgeR. Table A3: List of the putative target genes. Table A4: Complete output from DIANA-miRPath v.3. Table A5: Comparison of studies investigating miRNAs from brain samples. Figure A1: Stratified nested cross-validation. Figure A2: Expression heatmap of miRNA signature. Figure A3: Bootstrapped ROC AUC scores. Figure A4: ROC AUC scores with 100 different fold splits. Figure A5: Presymptomatic subjects probability scores. Figure A6: Heatmap of the level of enrichment in KEGG pathways. Kmetzsch V, et al. J Neurol Neurosurg Psychiatry 2021; 92:485–493. doi: 10.1136/jnnp-2020-324647 BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance Supplemental material placed on this supplemental material which has been supplied by the author(s) J Neurol Neurosurg Psychiatry Appendix A1. Neuropsychological protocol The PREV-DEMALS cognitive evaluation included standardized neuropsychological tests to investigate all cognitive domains, and in particular frontal lobe functions. The scores were provided previously (Bertrand et al., 2018). Briefly, global cognitive efficiency was evaluated by means of Mini-Mental State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS). Frontal executive functions were assessed with Frontal Assessment Battery (FAB), forward and backward digit spans, Trail Making Test part A and B (TMT-A and TMT-B), Wisconsin Card Sorting Test (WCST), and Symbol-Digit Modalities test.
    [Show full text]
  • The University of Chicago Genetic Services Laboratories Labolaboratories
    The University of Chicago Genetic Services Laboratories LaboLaboratories5841 S. Maryland Ave., Rm. G701, MC 0077, Chicago, Illinois 60637 3637 [email protected] dnatesting.uchicago.edu CLIA #: 14D0917593 CAP #: 18827-49 Next Generation Sequencing Panel for Albinism Clinical Features: Albinism is a group of inherited disorders in which melanin biosynthesis is reduced or absent [1]. The lack or reduction in pigment can affect the eyes, skin and hair, or only the eyes. In addition, there are several syndromic forms of albinism in which the hypopigmented and visual phenotypes are seen in addition to other systems involvement [2]. Our Albinism Sequencing Panel includes sequence analysis of all 20 genes listed below. Our Albinism Deletion/Duplication Panel includes sequence analysis of all 20 genes listed below. Albinism Sequencing Panel Chediak- Griscelli Oculocutaneous Ocular Hermansky Pudlak syndrome Higashi syndrome Albinism Albinism syndrome TYR SLC45A2 GPR143 HPS1 HPS4 DTNBP1 LYST MYO5A OCA2 SLC24A5 AP3B1 HPS5 BLOC1S3 RAB27A TYRP1 C10ORF11 HPS3 HPS6 BLOC1S6 MLPH Oculocutaneous Albinism Oculocutaneous albinism (OCA) is a genetically heterogeneous congenital disorder characterized by decreased or absent pigmentation in the hair, skin, and eyes. Clinical features can include varying degrees of congenital nystagmus, hypopigmentation and translucency, reduced pigmentation of the retinal pigment epithelium and foveal hypoplasia. Vision acuity is typically reduced and refractive errors, color vision impairment and photophobia also occur [3]. Gene Clinical Features Details TYR Albinism, OCA1 is caused by mutations in the tyrosinase gene, TYR. Mutations completely oculocutaneous, abolishing tyrosinase activity result in OCA1A, while mutations rendering some type I enzyme activity result in OCA1B allowing some accumulation of melanin pigment production throughout life.
    [Show full text]
  • Cellular and Molecular Defects in a Patient with Hermansky-Pudlak Syndrome Type 5
    RESEARCH ARTICLE Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5 Joshi Stephen1☯, Tadafumi Yokoyama1☯, Nathanial J. Tolman2☯, Kevin J. O'Brien1, Elena- Raluca Nicoli2, Brian P. Brooks3, Laryssa Huryn3, Steven A. Titus4, David R. Adams2,5, Dong Chen6, William A. Gahl1,2,5, Bernadette R. Gochuico1³*, May Christine V. Malicdan2,5³ 1 Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, United States of America, 2 NIH Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, Maryland, United States of America, a1111111111 3 Ophthalmic Genetics & Visual Function Branch, National Eye Institute, National Institutes of Health, a1111111111 Bethesda, Maryland, United States of America, 4 Division of Pre-clinical Innovation, National Center for a1111111111 Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America, 5 Office of the Clinical Director, National Human Genome Research Institute, National Institutes of a1111111111 Health, Bethesda, Maryland, United States of America, 6 Division of Hematopathology, Mayo Clinic, a1111111111 Rochester, Minnesota, United States of America ☯ These authors contributed equally to this work. ³ These authors also contributed equally to this work. * [email protected] OPEN ACCESS Citation: Stephen J, Yokoyama T, Tolman NJ, O'Brien KJ, Nicoli E-R, Brooks BP, et al. (2017) Abstract Cellular and molecular defects in a patient with Hermansky-Pudlak syndrome type 5. PLoS ONE 12 Hermansky-Pudlak syndrome (HPS) is a heterogeneous group of genetic disorders typically (3): e0173682. https://doi.org/10.1371/journal. manifesting with tyrosinase-positive oculocutaneous albinism, bleeding diathesis, and pul- pone.0173682 monary fibrosis, in some subtypes.
    [Show full text]
  • Molecular Diagnostic Requisition
    BAYLOR MIRACA GENETICS LABORATORIES SHIP TO: Baylor Miraca Genetics Laboratories 2450 Holcombe, Grand Blvd. -Receiving Dock PHONE: 800-411-GENE | FAX: 713-798-2787 | www.bmgl.com Houston, TX 77021-2024 Phone: 713-798-6555 MOLECULAR DIAGNOSTIC REQUISITION PATIENT INFORMATION SAMPLE INFORMATION NAME: DATE OF COLLECTION: / / LAST NAME FIRST NAME MI MM DD YY HOSPITAL#: ACCESSION#: DATE OF BIRTH: / / GENDER (Please select one): FEMALE MALE MM DD YY SAMPLE TYPE (Please select one): ETHNIC BACKGROUND (Select all that apply): UNKNOWN BLOOD AFRICAN AMERICAN CORD BLOOD ASIAN SKELETAL MUSCLE ASHKENAZIC JEWISH MUSCLE EUROPEAN CAUCASIAN -OR- DNA (Specify Source): HISPANIC NATIVE AMERICAN INDIAN PLACE PATIENT STICKER HERE OTHER JEWISH OTHER (Specify): OTHER (Please specify): REPORTING INFORMATION ADDITIONAL PROFESSIONAL REPORT RECIPIENTS PHYSICIAN: NAME: INSTITUTION: PHONE: FAX: PHONE: FAX: NAME: EMAIL (INTERNATIONAL CLIENT REQUIREMENT): PHONE: FAX: INDICATION FOR STUDY SYMPTOMATIC (Summarize below.): *FAMILIAL MUTATION/VARIANT ANALYSIS: COMPLETE ALL FIELDS BELOW AND ATTACH THE PROBAND'S REPORT. GENE NAME: ASYMPTOMATIC/POSITIVE FAMILY HISTORY: (ATTACH FAMILY HISTORY) MUTATION/UNCLASSIFIED VARIANT: RELATIONSHIP TO PROBAND: THIS INDIVIDUAL IS CURRENTLY: SYMPTOMATIC ASYMPTOMATIC *If family mutation is known, complete the FAMILIAL MUTATION/ VARIANT ANALYSIS section. NAME OF PROBAND: ASYMPTOMATIC/POPULATION SCREENING RELATIONSHIP TO PROBAND: OTHER (Specify clinical findings below): BMGL LAB#: A COPY OF ORIGINAL RESULTS ATTACHED IF PROBAND TESTING WAS PERFORMED AT ANOTHER LAB, CALL TO DISCUSS PRIOR TO SENDING SAMPLE. A POSITIVE CONTROL MAY BE REQUIRED IN SOME CASES. REQUIRED: NEW YORK STATE PHYSICIAN SIGNATURE OF CONSENT I certify that the patient specified above and/or their legal guardian has been informed of the benefits, risks, and limitations of the laboratory test(s) requested.
    [Show full text]
  • MUTED Antibody - C-Terminal Region (ARP63301 P050) Data Sheet
    MUTED antibody - C-terminal region (ARP63301_P050) Data Sheet Product Number ARP63301_P050 Product Name MUTED antibody - C-terminal region (ARP63301_P050) Size 50ug Gene Symbol BLOC1S5 Alias Symbols DKFZp686E2287; MU; MUTED Nucleotide Accession# NM_201280 Protein Size (# AA) 187 amino acids Molecular Weight 21kDa Product Format Lyophilized powder NCBI Gene Id 63915 Host Rabbit Clonality Polyclonal Official Gene Full Name Muted homolog (mouse) Gene Family BLOC1S This is a rabbit polyclonal antibody against MUTED. It was validated on Western Blot by Aviva Systems Biology. At Aviva Systems Biology we manufacture rabbit polyclonal antibodies on a large scale (200-1000 Description products/month) of high throughput manner. Our antibodies are peptide based and protein family oriented. We usually provide antibodies covering each member of a whole protein family of your interest. We also use our best efforts to provide you antibodies recognize various epitopes of a target protein. For availability of antibody needed for your experiment, please inquire (). Partner Proteins BLOC1S2,DTNBP1,BLOC1S1,BLOC1S2,CNO,DTNBP1,SNAPIN,BLOC1S2,BLOC1S3,DTNBP1,PLDN,SQS TM1,YOD1 This gene encodes a component of BLOC-1 (biogenesis of lysosome-related organelles complex 1). Components of this complex are involved in the biogenesis of organelles such as melanosomes and platelet- Description of Target dense granules. A mouse model for Hermansky-Pudlak Syndrome is mutated in the murine version of this gene. Alternative splicing results in multiple transcript variants. Read-through transcription exists between this gene and the upstream EEF1E1 (eukaryotic translation elongation factor 1 epsilon 1) gene, as well as with the downstream TXNDC5 (thioredoxin domain containing 5) gene.
    [Show full text]
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation
    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
    [Show full text]